Method for stabilizing active ingredients using mineral materials
The production of microcapsules using emulsifier and encapsulating components addresses stability and biodegradability issues, ensuring stable and environmentally friendly encapsulation of active ingredients.
Patent Information
- Application Number
- JP2023540196
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-06-29
- Filing Date
- 2021-12-28
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2041-12-28
AI Technical Summary
Existing encapsulation technologies using inorganic materials like silica face issues with stability under tension and impact during drying, leading to cracking, while biodegradable polymers suffer from microporosity and instability, and cross-linking compromises biodegradability and stability under harsh conditions.
A method involving the production of microcapsules by mixing a continuous phase with an emulsifier and a dispersed phase containing encapsulating components and active ingredients, using silica, titanium dioxide, or zirconium oxide precursors, and a hardening reaction to form dense capsules.
The method produces stable microcapsules that maintain active ingredients, prevent leaching, and are environmentally friendly due to biodegradability, avoiding microplastic pollution.
Smart Images

Figure 0007948933000022 
Figure 0007948933000023 
Figure 0007948933000024
Abstract
Description
TECHNICAL FIELD
[0001] The present invention relates to a method for stabilizing an active ingredient using a mineral material. More specifically, the present invention relates to an active ingredient stabilization technology that can avoid the microplastic problem, and to a technology that can stably support an active ingredient using a mineral material that is not a microplastic. BACKGROUND ART
[0002] Encapsulation is a general term for forms in which an active ingredient is enclosed in a substance corresponding to an outer wall for effective delivery of the active ingredient. Such capsules can achieve accurate delivery suited to the purpose even with the use of a small dose of the active ingredient, reduce side effects, maintain the stability of the active ingredient, and reduce cost-related problems. As a result, capsules are applied in various industrial fields and for diverse purposes, including targeted drug delivery in the medical / pharmaceutical field, maintaining the stability of fragrances in hygiene products and releasing the fragrance at the time desired by the user, maintaining the stability of functional substances against external stimuli such as light and heat in the cosmetics field and delivering them to the skin, as well as maintaining the stability of insecticides and nutritional components and enhancing absorption efficiency in the agricultural and food fields.
[0003] However, international organizations point to microcapsules as one of the causes of microplastic pollution (small plastic fragments less than 5 mm in diameter) that accumulate in nature without decomposing and can cause serious environmental pollution. According to the ECHA report (2019), when using inorganic materials or biodegradable polymers as substances that can escape the microplastic problem, readyly biodegradable materials designed to decompose immediately were selected. However, capsules made from inorganic materials such as silica, which are not in the category of microplastics, have the problem of being weak against the tension and impact generated when drying and being prone to cracking. When capsules are made from natural polymers, the microporosity inherent to the material causes the active ingredients inside the capsule to leach out, and the stability of the capsule cannot be maintained. Furthermore, when cross-linking is used to reduce microporosity and increase stability, the decomposition rate decreases, and the material does not become biodegradable. In addition, when ester bonds are introduced into materials to make them easily decomposed, the dosage form cannot withstand harsh conditions (pH changes, temperature changes) and decomposes before use, and to this day, no solution is known or there are no solutions at all.
[0004] Silica, an inorganic material, is a safe substance that does not affect living organisms and is widely used in pharmaceuticals, cosmetics, and daily necessities. Silica makes up the majority of soil components, which constitute the earth, and in the case of diatoms, a type of microorganism, it is a component of their cell walls, making it a safe substance. Therefore, research into encapsulating active ingredients using silica is gaining attention. However, as mentioned earlier, unlike polymers, silica easily breaks due to the tension generated during drying, so research to address this issue is necessary. [Prior art documents] [Non-patent literature]
[0005] [Non-Patent Document 1] :ANNEX XV RESTRICTION REPORT,PROPOSAL FOR A RESTRICTION;SUBSTANCE NAME(S):intentionally added microplastics,DATE:22 August 2019 [Overview of the Initiative] [Problems that the invention aims to solve]
[0006] The inventors of the present invention conducted research to develop microcapsules using inorganic mineral materials. As a result, they found that when a continuous phase containing an emulsifier is mixed with a dispersed phase containing encapsulating components and an active ingredient, and then microcapsules containing the active ingredient are produced through a hardening reaction of the encapsulating components, the encapsulating components are the same as soil components, and therefore there are no environmental problems when they are naturally discharged. This led to the completion of the present invention.
[0007] Therefore, the object of the present invention is to provide a method for producing microcapsules having high versatility, affinity to nature, and stability, microcapsules produced thereby, and laundry products containing said microcapsules. [Means for solving the problem]
[0008] The present invention relates to the step of producing an emulsion by mixing a continuous phase containing an emulsifier with a dispersed phase containing encapsulating components and active ingredients, and The step includes encapsulating the emulsion, The emulsifier comprises at least one selected from the group consisting of anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants. The present invention provides a method for producing microcapsules, wherein the encapsulation component comprises at least one selected from the group consisting of silica precursor, titanium dioxide precursor, and zirconium oxide precursor.
[0009] Furthermore, the present invention provides microcapsules manufactured by the above-mentioned method for manufacturing microcapsules, with a particle size of 0.1 to 1,000 μm.
[0010] Furthermore, the present invention provides a laundry product containing the aforementioned microcapsules.
[0011] Furthermore, the present invention provides applications for microcapsules with a particle size of 0.1 to 1,000 μm, which are manufactured by the aforementioned method for manufacturing microcapsules for the production of laundry products. [Effects of the Invention]
[0012] This invention provides a method for stabilizing active ingredients using mineral materials.
[0013] In this invention, active ingredients can be stably supported using mineral materials, and since the encapsulated components of the microcapsules produced by the manufacturing method according to this invention are the same as those of soil, there are no environmental problems when they are naturally discharged, thus avoiding the problem of microplastics. Furthermore, since the microcapsules produced by the manufacturing method according to this invention have a dense capsule outer wall, the leaching of active ingredients can be prevented. [Brief explanation of the drawing]
[0014] [Figure 1] This diagram illustrates the method for producing microcapsules according to the present invention. [Figure 2] The results of morphological examination of microcapsules manufactured according to the embodiments of the present invention using a scanning electron microscope (SEM) are shown below. Specifically, A is an SEM image of Example 8, B is a magnified image of Example 8, C is a fractured surface image of Example 8, and D is a fractured surface image of Example 40. [Figure 3] The results of checking the particle size of the microcapsules produced in Example 8 of the present invention using Mastersizer3000 are shown. [Figure 4]The results of confirming the retained amount of fragrance inside the capsules over time in an environment of 50°C in the presence of an emulsifier for the microcapsules produced in Examples 8 and 40 of the present invention are shown. DETAILED DESCRIPTION OF THE EMBODIMENTS
[0015] The present invention relates to a method for producing microcapsules, comprising the steps of mixing a continuous phase containing an emulsifier with a dispersed phase containing an encapsulating component and an active ingredient to produce an emulsion, and subjecting the emulsion to an encapsulation reaction, wherein the emulsifier comprises at least one selected from the group consisting of anionic surfactants, cationic surfactants, amphoteric surfactants and nonionic surfactants, and the encapsulating component comprises at least one selected from the group consisting of silica precursors, titanium oxide precursors and zirconium oxide precursors.
[0016] Hereinafter, the constitution of the present invention will be specifically described.
[0017] In the present invention, the term "microcapsule" means fine particles surrounding a liquid-phase, solid-phase or paste-form active ingredient, and may have a particle size of 0.1 to 1,000 μm. The microcapsules can physically and chemically protect the active ingredient from the external environment, and can also regulate the release of the active ingredient.
[0018] In the present invention, the microcapsules may be produced by a step of mixing a continuous phase containing an emulsifier with a dispersed phase containing an encapsulating component and an active ingredient to produce an emulsion (hereinafter referred to as the emulsion production step), and a step of subjecting the emulsion to an encapsulation reaction (hereinafter referred to as the encapsulation reaction step).
[0019] In the present invention, the emulsion production step may be a step of mixing a continuous phase and a dispersed phase to produce an emulsion.
[0020] In the present invention, the continuous phase may contain an emulsifier as an aqueous phase.
[0021] In one specific example, all solvents commonly used in the art may be used as the solvent for the continuous phase, and specifically, distilled water may be used.
[0022] In one specific example, the emulsifier is a substance used as a framework so that the encapsulation component described later can be converted into the outer wall of the capsule. As such an emulsifier, any emulsifier commonly used in the art may be used, and specifically, at least one selected from the group consisting of anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants may be used.
[0023] As the cationic surfactant, at least one selected from the group consisting of trimethylalkylammonium salts, dialkyldimethylammonium salts, alkylbenzylmethylammonium salts and the like may be used; as the anionic surfactant, at least one selected from the group consisting of sodium fatty acid salts, monoalkyl sulfates, alkyl polyoxyethylene sulfates, alkylbenzene sulfonates, monoalkyl phosphates and the like may be used; as the amphoteric surfactant, at least one selected from the group consisting of alkyl sulfobetaines, alkyl carboxybetaines and the like may be used; and as the nonionic surfactant, at least one selected from the group consisting of fatty alcohols, polyoxyethylene alkyl ethers, fatty acid sorbitan esters, fatty acid diethanolamides, alkyl monoglyceryl ethers and the like may be used.
[0024] Preferably, the emulsifier may be a cationic surfactant, and specifically, cetyltrimethylammonium bromide (CTAB) or cetyltrimethylammonium chloride (CTAC) may be used. The CTAB or CTAC not only exerts an emulsification effect, but also promotes hydrolysis and reaction at the interface through the amine groups present in its structure, so that a more uniform reaction can be induced, and dense microcapsules can be produced.
[0025] In one specific example, the content of the emulsifier is not particularly limited and may be present in amounts of 0.00001 to 10 parts by weight, 0.0001 to 10 parts by weight, 0.0002 to 5 parts by weight, 0.0005 to 2 parts by weight, or 0.002 to 1.2 parts by weight relative to the total weight (100 parts by weight) of the emulsion. If the content of the emulsifier is less than 0.00001 parts by weight, there is a problem that emulsification will not occur, and if it exceeds 10 parts by weight, there is too much emulsifier component, and there is a risk that the active ingredient in the capsule will dissolve.
[0026] In the present invention, the dispersed phase includes an encapsulating component and an active ingredient as an oil phase.
[0027] In one specific example, the solvent of the dispersed phase is not particularly limited as long as it is a solvent that does not mix with the continuous phase. When distilled water is used as the solvent of the continuous phase, at least one selected from the group consisting of hydrocarbon solvents, solvents containing ether groups, solvents containing ester groups, solvents containing ketone groups, solvents containing benzene, haloalkane solvents, and silicone solvents may be used as the solvent of the dispersed phase.
[0028] The hydrocarbon solvent may be selected from linear or nonlinear compounds such as pentane, hexane, cyclohexane, heptane, octane, isododecane, and dodecane; the solvent containing an ether group may be selected from ethyl ether, butyl ether, and methyl-t-butyl ether; and the solvent containing an ester group may be selected from ethyl acetate, butyl acetate, and ethyl butyrate. Furthermore, the solvent containing a ketone group may be methyl ethyl ketone, the solvent containing benzene may be selected from benzene, toluene, and xylene, the haloalkane solvent may be selected from dichloromethane, dichloroethane, chloroform, and carbon tetrachloride, and the silicone solvent may be selected from dimethicone and cyclomethicone.
[0029] In the present invention, the encapsulating component is a component that constitutes the outer wall of the capsule, and may be converted into a mineral material during the encapsulation reaction. The encapsulation reaction may also be a hydrolysis reaction.
[0030] In one specific example, a mineral material precursor may be used as the encapsulation component, and the mineral material precursor may be at least one selected from the group consisting of silica precursor, titanium dioxide precursor, and zirconium oxide precursor.
[0031] In one specific example, the mineral material precursor may include at least one compound selected from the group consisting of compounds represented by the following chemical formulas 1 to 4.
[0032] [ka]
[0033] [ka]
[0034] [ka]
[0035] [ka]
[0036] In the above formulas 1 to 4, A may be silicone, titanium, or zirconium, and R1 to R4 may each be independently a hydrogen atom or an alkyl group having 1 to 8 carbon atoms with a substituted or unsubstituted functional group at the terminal, and the functional group may include amine, hydroxyl, amide, carboxy, vinyl, epoxy, phenyl, or mercapto.
[0037] In one specific example, the silica precursor may include at least one selected from the group consisting of tetramethyl orthosilicate, tetraethyl orthosilicate, tetrapropyl orthosilicate, tetrabutyl orthosilicate, methyl trimethoxysilicate, dimethyl dimethoxysilicate, trimethyl methoxysilicate, trimethyl ethoxysilicate, butyl trimethoxysilicate, N-propyltrimethoxysilane, N-octyltrimethoxysilane, aminopropyltrimethoxysilicate, phenyltrimethoxysilane, 3-mercaptopropyltrimethoxysilane, and methyldimethoxysilane; the titanium oxide precursor may include at least one selected from the group consisting of titanium methoxide, titanium ethoxide, and titanium butoxide; and the zirconium oxide precursor may include at least one selected from the group consisting of zirconium methoxide, zirconium ethoxide, and zirconium butoxide.
[0038] In one specific example, the content of the encapsulating component is not particularly limited and may be 0.001 to 30 parts by weight, 0.01 to 25 parts by weight, or 0.1 to 20 parts by weight relative to the total weight (100 parts by weight) of the emulsion. If the content of the encapsulating component is less than 0.001 parts by weight, there is a risk that even if the encapsulation reaction occurs, the outer wall of the capsule will be formed so thinly that it cannot be maintained, and if it exceeds 30 parts by weight, there is a risk that the distinction between the dispersed phase and the continuous phase will become ambiguous, and capsules will not be formed.
[0039] In the present invention, the active ingredient is a substance whose activity is desired to be maintained by the generated capsule, and the active ingredient can subsequently express its activity when the outer wall of the capsule is destroyed. If the active ingredient is a liquid at room temperature, it may be replaced with a dispersed phase which is a solvent. As such an active ingredient, at least one selected from the group consisting of fragrances, UV blockers, dyes, catalysts, antioxidants, and drugs may be used.
[0040] In one specific example, when the active ingredient is a fragrance, the present invention may provide a fragrance product containing microcapsules. The fragrance product may include a fragrance spray, a liquid fragrance product, a cleaning agent, a facial cleanser, a body product, a hair product, or a laundry product. The laundry product refers to a product applied to clothing and may include, but is not limited to, laundry detergents, fabric softeners, fragrance additives, clothing deodorizers, dry cleaning agents, stain removers, bleaches, and the like.
[0041] When the active ingredient is a UV-blocking agent, the present invention may provide a cosmetic composition for UV blocking that includes microcapsules. The UV-blocking agent may be an inorganic UV-blocking agent such as titanium dioxide (TiO2), zinc oxide (ZnO), silicates, or talc, or an organic UV-blocking agent such as isoamyl-p-methoxycinnamate, octylmethoxycinnamate, ethylhexyl triazone, oxybenzone, diethylaminohydroxybenzoylhexylbenzoate, octocrylene octyl salicylate, butyl methoxydibenzoylmethane, octyl salicylate, benzophenone, or anthranilate.
[0042] Furthermore, when the active ingredient is a functional substance or a poorly soluble substance, the microcapsules of the present invention can be provided as a carrier for improving the stability of the functional substance or poorly soluble substance. The functional substance or poorly soluble substance may include antioxidants such as retinol or resveratrol, poorly soluble substances such as cholesterol or ceramide, and hot and cold sensation stimulants such as menthol or vanillyl butyl ether.
[0043] In one specific example, the content of the active ingredient is not particularly limited and may be 0.001 to 20 parts by weight, 0.01 to 15 parts by weight, or 1 to 10 parts by weight relative to the total weight (100 parts by weight) of the emulsion.
[0044] In one specific example, the content of the encapsulating component may be 0.5 to 3 times the content of the active ingredient. If the content of the encapsulating component exceeds 3 times the content of the active ingredient, there is a risk of gelation due to aggregation between particles, and if it is less than 0.5 times, there is a risk of phase separation, so it is preferable to maintain the content ratio between 0.5 and 3 times.
[0045] Furthermore, in one specific example, the content of the encapsulating component and active ingredient may be 35 parts by weight or less relative to the total weight (100 parts by weight) of the emulsion, specifically 10 to 35 parts by weight, 11 to 35 parts by weight, or 15 to 30 parts by weight. If the content of the encapsulating component and active ingredient exceeds 35 parts by weight, the active ingredient may not stabilize easily, and instead, agglomeration between particles may occur, potentially leading to gelation. Also, if the content of the encapsulating component and active ingredient is less than 10 parts by weight, phase separation may occur.
[0046] In the emulsion production stage of the present invention, the emulsion may be produced by mixing the continuous phase and dispersed phase described above.
[0047] In one specific example, the content of the dispersed phase may be 35 parts by weight or less, 10 to 35 parts by weight, 11 to 35 parts by weight, or 15 to 30 parts by weight, based on the mixed weight (100 parts by weight) of the dispersed phase and the continuous phase.
[0048] In one specific example, the emulsion production step may be carried out by adding the dispersed phase to the continuous phase, or under stirring.
[0049] In one specific example, stirring may be performed at 20-30°C or room temperature at speeds of 1-16,000 RPM, 5-13,000 RPM, or 10-10,000 RPM. The stirring time may also vary depending on the volume of emulsion being produced.
[0050] In the present invention, the encapsulation reaction step is a step in which the emulsion produced in the emulsion production step described above is encapsulated to produce microcapsules.
[0051] As shown in Figure 1, stable microcapsules containing the active ingredient may be produced through a curing reaction (or solidification reaction) of the encapsulating component. Specifically, since the encapsulating component contains an alkoxy, it is initially mixed with the dispersed phase, which is the core substance. However, when hydrolysis occurs at the emulsion interface, the encapsulating component becomes hydrophilic and is laminated at the interface. During this process, a solidification reaction occurs, and a solid outer wall is formed.
[0052] In one specific example, the time interval between the emulsion production step and the encapsulation reaction step may be between 1 hour and 14 days.
[0053] In one specific example, the encapsulation reaction step may be carried out under weakly acidic conditions. The weakly acidic conditions may be pH 2 to 5 or pH 2 to 4. The outer wall of a dense capsule may be manufactured under these weakly acidic conditions. If the pH is outside the above range, desired micro-sized particles (capsules) may not be formed, or even if particles are formed, the outer wall may be thin, or porous particles may be formed, preventing the active ingredient from being stably supported inside the capsule and potentially leading to easy elution.
[0054] In one specific example, the encapsulation reaction for the production of microcapsules may be carried out at 20-30°C or room temperature for 10 minutes to 48 hours. If the temperature is raised to accelerate the reaction, micro-sized particles (capsules) may not be formed, or even if particles are formed, the thickness of the outer wall may be thin, or porous particles may be formed. Therefore, it is preferable to adjust the reaction temperature and time as described above.
[0055] In one specific example, the encapsulation reaction may be carried out while the emulsion is left to stand without stirring. Specifically, the present invention may form a dense capsule outer wall by carrying out the encapsulation reaction while the emulsion is left to stand without increasing the reaction rate.
[0056] In one specific example, the encapsulation reaction may be carried out one or more times, specifically two to three times. The secondary encapsulation reaction may be carried out by adding the encapsulating component to the emulsion after the primary encapsulation reaction is complete and allowing the reaction to proceed. The encapsulating component used in the secondary encapsulation reaction may be the same as the encapsulating component used in the primary reaction, or a different type of encapsulating component may be used.
[0057] When the encapsulation reaction is carried out twice, microcapsules with double walls may be produced. When produced with double walls, the silica content increases, making the capsule itself thicker, which allows for stable storage of the active ingredient even in harsh environments.
[0058] Furthermore, the present invention relates to microcapsules manufactured by the microcapsule manufacturing method described above.
[0059] The average particle size of the microcapsules according to the present invention may be 0.1 to 1,000 μm, 0.1 to 100 μm, 0.5 to 80 μm, or 1 to 5 μm. If the average particle size of the microcapsules is less than 0.1 μm, the amount of active ingredient supported in the capsule may be too small, resulting in insufficient expression of the active ingredient even when the microcapsules are applied, and thus the effect may not be observed. Furthermore, if the average particle size exceeds 1,000 μm, there is a problem that the microcapsules can easily break due to the tension generated when the mineral material capsule dries.
[0060] Furthermore, the thickness of the capsule's outer wall may be 0.01 to 1 μm.
[0061] Furthermore, the present invention relates to a laundry product containing the aforementioned microcapsules.
[0062] In one specific example, the laundry product may include laundry detergent, fabric softener, fragrance additive, clothing deodorizer, dry cleaning agent, stain remover, bleach, etc.
[0063] In one specific example, the content of microcapsules in a laundry product may be 0.5 to 20 parts by weight or 1 to 10 parts by weight relative to the total weight.
[0064] Furthermore, the present invention relates to the use of microcapsules manufactured by the aforementioned method for manufacturing microcapsules, with a particle size of 0.1 to 1,000 μm, for the manufacture of laundry products.
[0065] Modes for carrying out the invention The present invention will now be described in detail through examples. The following examples are illustrative of the present invention and the scope of the invention is not limited to these examples. These examples are provided to complete the disclosure of the present invention and to fully inform those who are ordinary skill in the art to which the invention pertains, and the present invention is defined only by the scope of the claims.
[0066] Examples The raw materials used in the following examples, comparative examples, and experimental examples were purchased from commercial cosmetic raw material suppliers or reagent suppliers.
[0067] Examples 1-10. Production of microcapsules using encapsulating components Microcapsules were manufactured according to the composition and content shown in Table 1 below. First, a continuous phase was prepared by dissolving an emulsifier (CTAB) in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing the encapsulation components and fragrance (perfume). The dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions.
[0068] On the other hand, in Comparative Example 1, an emulsified solution was prepared by emulsifying the fragrance according to the composition and content shown in Table 1.
[0069] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Next, the fragrance of the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion.
[0070] Except for Experimental Example 6, the manufactured microcapsules were stabilized for 24 hours under constant temperature and humidity conditions of 30°C and 50% humidity before being used.
[0071] [Table 1]
[0072] Experiment Example 1: Evaluation of fragrance intensity after washing. A washing evaluation was conducted to confirm the residual fragrance enhancement performance of the microcapsules produced in Examples 1-10 and Comparative Example 1.
[0073] First, four commercially available cotton towels (30cm x 20cm) (100% cotton, manufactured by Sonwol Towel Co., Ltd.) were used as test fibers. The cotton towels were washed five times in a washing machine using the standard amount of general laundry detergent, and then spun dry (first wash).
[0074] Based on 100 parts by weight of the total composition, 5 parts by weight of microcapsules prepared in Examples 1-10 and Comparative Example 1 were added to an aqueous solution containing 5 parts by weight of CTAB and immediately treated with cotton towels. Specifically, the towels were washed using a household automatic washing machine with 45 L of water, 10 minutes of rinsing, and 5 minutes of spinning (second wash). Next, the cotton towels were dried at 30% humidity and 25°C for 12 hours.
[0075] At this time, three time points (immediately after washing, after drying, and after friction) were set, and 20 experienced panelists in their 20s to 40s performed sensory evaluations to assess the intensity of the fragrance. "Immediately after washing" refers to the time when the second wash was completed, "after drying" refers to the time after drying in a constant temperature and humidity room for 12 hours, and "after friction" refers to the time after the dried cotton towel was folded horizontally into four equal parts twice, rotated 90 degrees, held by both hands, and then rubbed gently in a circular motion three times with the towel positioned between the hands.
[0076] The intensity of the aforementioned fragrance was determined by setting a baseline of 0 points for cotton towels without microcapsule treatment, assigning points from a minimum of 0 to a maximum of 5 points, and repeating this process at least three times to calculate the average value.
[0077] Table 2 below shows the results of sensory evaluations conducted on cotton towels after washing, following the preparation of compositions containing microcapsules.
[0078] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0079] [Table 2]
[0080] As shown in Table 2 above, when using the microcapsules according to the present invention, it can be confirmed that the fragrance emission of the microcapsules is more pronounced compared to Comparative Example 1. In particular, when a silica precursor is used as the encapsulation component, it can be confirmed that the fragrance emission is high, with a fragrance intensity of 3 or higher after friction.
[0081] The reason for the superior fragrance release after drying is believed to be that some of the larger microcapsule particles broke during the drying process, releasing their fragrance.
[0082] Examples 11-20. Production of microcapsules using different types of emulsifiers Microcapsules were manufactured according to the composition and content shown in Table 3.
[0083] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing TEOS and fragrance (perfume). Next, the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions.
[0084] [Table 3]
[0085] Experimental Example 2: Evaluation of Scent Intensity After Washing To confirm the fragrance enhancement performance of the microcapsules produced in Examples 11-20, a washing evaluation was conducted.
[0086] The fragrance enhancement performance of these microcapsules was determined using the method described in Experimental Example 1.
[0087] The results of the sensory evaluation are shown in Table 4 below.
[0088] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0089] [Table 4]
[0090] As shown in Table 4 above, it can be confirmed that when using microcapsules containing fragrance oil, the lingering fragrance after friction is excellent.
[0091] Generally, microcapsules manufactured using cationic emulsifiers exhibited high fragrance retention, followed by nonionic and then anionic emulsifiers, in that order of decreasing fragrance retention. This suggests that when manufactured using cationic emulsifiers, the encapsulation reaction occurs uniformly at the interface, resulting in high fragrance oil preservation and a strong lingering fragrance after friction.
[0092] Examples 21-22. Production of surface-modified microcapsules Microcapsules were manufactured according to the composition and content shown in Table 5.
[0093] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing TEOS, a silica precursor, and a fragrance. Next, the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions.
[0094] [Table 5]
[0095] Experiment Example 3. Evaluation of fragrance intensity after washing. To confirm the fragrance enhancement performance of the microcapsules produced in Examples 21-22, a washing evaluation was conducted.
[0096] The fragrance enhancement performance of these microcapsules was evaluated using the method described in Experimental Example 1.
[0097] The results of the sensory evaluation are shown in Table 6 below.
[0098] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0099] [Table 6]
[0100] As shown in Table 6 above, it can be confirmed that the residual fragrance is maintained even when the surface of the microcapsules is modified with functional groups.
[0101] Examples 23-32. Production of microcapsules with size adjusted according to emulsifier content. Microcapsules were manufactured according to the composition and content shown in Table 7.
[0102] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing each TEOS and fragrance. Next, the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions.
[0103] In particular, in Examples 31 and 32, in order to produce smaller microcapsules, the Tip sonicator was treated for 5 minutes after the emulsion production process, and then the encapsulation reaction was carried out under weakly acidic conditions.
[0104] [Table 7]
[0105] Experimental Example 4. Measurement of Microcapsule Particle Size The particle size of the microcapsules produced in Examples 23-32 was measured.
[0106] Particle size was measured using a Matersizer 3000 (Malvern, UK).
[0107] When 0.0001% of the emulsifier was used (Example 23), phase separation occurred without emulsification. However, when 0.0005% or more was used, emulsification began, and it was confirmed that microcapsules were produced.
[0108] In particular, Figure 3 shows the particle size measurement results of the microcapsules produced in Example 8, confirming that the microcapsules have an average particle size of 1.5 μm.
[0109] Experiment Example 5. Evaluation of fragrance intensity after washing. To confirm the fragrance enhancement performance of the microcapsules produced in Examples 23-32, a washing evaluation was conducted.
[0110] The fragrance enhancement performance of these microcapsules was evaluated using the method described in Experimental Example 1.
[0111] The results of the sensory evaluation are shown in Table 8 below.
[0112] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0113] [Table 8]
[0114] As shown in Table 8 above, it can be confirmed that the smaller the microcapsule size, the greater the residual fragrance. This is because, as the particles get larger, the capsules cannot withstand the tension acting on their surface and break, thus failing to maintain the residual fragrance. Furthermore, it can be confirmed that when an emulsifier of 0.1% by weight or more is used, there is almost no variation in particle size, and the residual fragrance is similarly affected.
[0115] Furthermore, when producing small-sized particles through sonicator processing, it can be confirmed that residual fragrance begins to decrease from 0.5 μm in size.
[0116] Examples 33-38 and Comparative Examples 2-3: Production of microcapsules by microcapsule shell composition Microcapsules were manufactured according to the composition and content shown in Table 9.
[0117] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing TEOS and fragrance. Next, the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions.
[0118] [Table 9]
[0119] The results of observing the changes at room temperature for 28 days according to the TEOS content showed that when 0.1% by weight of TEOS was used, the capsules were not properly formed and phase separation occurred; when 30% by weight or more was used, gelling began; and when 50% by weight or more was used, gel formation occurred.
[0120] Examples 39-43. Production of double-walled microcapsules Microcapsules were manufactured according to the composition and content shown in Table 10.
[0121] First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing each TEOS and fragrance. Next, the dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion, and the encapsulation reaction was carried out under weakly acidic conditions. Then, 1-9% of TEOS was added, and the mixture was stirred at 400 rpm to carry out a further encapsulation reaction.
[0122] [Table 10]
[0123] Experiment Example 6. Evaluation of fragrance intensity after washing. To confirm the fragrance enhancement performance of the microcapsules produced in Examples 39-43, a washing evaluation was conducted. Before washing, the microcapsules were placed in a 5% CTAB solution and stored at 50°C for one month.
[0124] The fragrance enhancement performance of these microcapsules was evaluated using the method described in Experimental Example 1. The results of the sensory evaluation are shown in Table 11 below.
[0125] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0126] [Table 11]
[0127] As shown in Table 11 above, it can be confirmed that the higher the silica content in the microcapsule shell, the better the microcapsule maintains its fragrance even in harsh environments (environments with high temperatures and high levels of surfactants). This is judged to be a result of the capsule itself becoming thicker.
[0128] Figure 2D is an SEM image of the microcapsules produced in Example 40, and it can be seen that the surface is smoother and the thickness has increased from 22 nm to 38 nm compared to Figure 2C, which corresponds to Example 8.
[0129] Experimental Example 7. Evaluation of Microcapsules To confirm that the outer wall (shell) of the microcapsules was properly manufactured, the microcapsules manufactured in Example 8 were placed in ethanol, and after extracting the fragrance for a sufficient amount of time, they were centrifuged using centrifuge. Next, water was added and dispersed, and then freeze-dried to obtain fine silica particles in powder form, and the morphology of the microcapsules was confirmed using scanning electron microscopy.
[0130] Figure 2 shows the results of confirming the morphology of the microcapsules. As shown in Figures 2A and 2B, it can be confirmed that an outer wall made of mineral material is formed on the surface of the microcapsules.
[0131] Meanwhile, to confirm the stability of the microcapsules, 5 parts by weight each of the microcapsules produced in Example 8 and 40 were added to an aqueous solution containing 5 parts by weight of CTAB, based on 100 parts by weight of the total composition, and then stored in a chamber at 50°C for 4 weeks. Samples were taken on days 1, 2, 5, 7, 10, 14, 20, and 28. After filtering the microcapsules with a 0.45 μm syringe filter, the solution was placed in ethanol, and the remaining fragrance inside the microcapsules was measured using a sonicator and absorbance measurement with a UV-Vis spectrophotometer to determine the actual concentration.
[0132] Figure 4 shows the results of confirming the stability of the microcapsules.
[0133] As shown in Figure 4, in Example 40, it was confirmed that the fragrance was maintained at approximately 80% for 4 weeks even at 50°C. This indirectly confirms that microcapsules can maintain fragrance for a long period of time even under harsh conditions containing a large amount of surfactant.
[0134] Examples 44-55. Production of microcapsules by pH Microcapsules were manufactured according to the composition and content shown in Table 12 below. First, a continuous phase was prepared by dissolving an emulsifier in distilled water. Simultaneously, a dispersed phase was prepared by thoroughly mixing the encapsulation components and fragrance (perfume). The dispersed phase was added to the continuous phase and stirred at 8,000 rpm to produce an emulsion.
[0135] Next, the pH of the emulsion was adjusted using 1.0N HCl and 1.0N NaOH as shown in Table 12, and then the encapsulation reaction was carried out.
[0136] [Table 12]
[0137] During the manufacturing process of microcapsules, phase separation occurred when the pH was below 2 or above 6, instead of forming microcapsules. However, at pH levels between 2 and 5.5, the emulsified state was maintained even after the encapsulation reaction.
[0138] Experiment Example 8. Evaluation of fragrance intensity after washing. To confirm the pH-dependent fragrance enhancement performance of the microcapsules produced in Examples 46-52, a washing evaluation was conducted. Before washing, the microcapsules were placed in a 5% CTAB solution and stored at 50°C for one month.
[0139] The fragrance enhancement performance of these microcapsules was evaluated using the method described in Experimental Example 1. The results of the sensory evaluation are shown in Table 13 below.
[0140] <Evaluation Criteria> 0 points: Almost no scent remains. 5 points: The scent lingers a lot.
[0141] [Table 13]
[0142] As shown in Table 13 above, it can be confirmed that microcapsules manufactured at a pH of 2-4 have high fragrance preservation capabilities.
[0143] This means that in order to produce microcapsules with minimal defects, manufacturing must be done in an appropriate pH environment, and that only by manufacturing at a pH of 2-4 can microcapsules be produced that can preserve the active ingredients for extended periods. [Industrial applicability]
[0144] In this invention, active ingredients can be stably supported using mineral materials, and since the encapsulated components of the microcapsules produced by the manufacturing method according to this invention are the same as those of soil, there are no environmental problems when they are naturally discharged, thus avoiding the problem of microplastics. Furthermore, since the microcapsules produced by the manufacturing method according to this invention have a dense capsule outer wall, the leaching of active ingredients can be prevented.
Claims
1. A step of producing an emulsion by mixing a continuous phase containing an emulsifier with a dispersed phase containing encapsulating components and active ingredients, and A method for producing microcapsules, comprising the step of encapsulating the emulsion, The encapsulation reaction is carried out without stirring. The encapsulation reaction is carried out at a pH of 2 to 5. The emulsifier comprises at least one selected from the group consisting of anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants. The encapsulating component comprises at least one selected from the group consisting of silica precursor, titanium oxide precursor, and zirconium oxide precursor. By the above manufacturing method, microcapsules having a particle size of 0.1 to 8.9 μm are prepared. Manufacturing method.
2. The method for producing microcapsules according to claim 1, wherein the emulsifier is a cationic surfactant.
3. The method for producing microcapsules according to claim 1, wherein the emulsifier is cetyltrimethylammonium bromide (CTAB) or cetyltrimethylammonium chloride (CTAC).
4. The method for producing microcapsules according to claim 1, wherein the emulsifier content is 0.00001 to 10 parts by weight relative to the total weight of the emulsion.
5. A method for producing microcapsules according to claim 1, wherein the encapsulating component comprises at least one selected from the group consisting of compounds represented by the following chemical formulas 1 to 4. 【Chemistry 1】 【Chemistry 2】 【Transformation 3】 【Chemistry 4】 In the above formulas 1 to 4, A is silicone, titanium, or zirconium, and R 1 ~R 4 Each of these is independently a C1-C8 alkyl group with a functional group substituted or unsubstituted at a hydrogen atom or terminal, and the functional group includes amine, hydroxyl, amide, carboxyl, vinyl, epoxy, phenyl, or mercapto.
6. The silica precursor comprises at least one selected from the group consisting of tetramethyl orthosilicate, tetraethyl orthosilicate, tetrapropyl orthosilicate, tetrabutyl orthosilicate, methyl trimethoxysilicate, trimethyl ethoxysilicate, butyl trimethoxysilicate, N-propyltrimethoxysilane, N-octyltrimethoxysilane, aminopropyltrimethoxysilicate, phenyltrimethoxysilane, and 3-mercaptopropyltrimethoxysilane. The titanium dioxide precursor comprises at least one selected from the group consisting of titanium methoxide, titanium ethoxide, and titanium butoxide. The method for producing microcapsules according to claim 1, wherein the zirconium oxide precursor comprises at least one selected from the group consisting of zirconium methoxide, zirconium ethoxide, and zirconium butoxide.
7. The method for producing microcapsules according to claim 1, wherein the content of the encapsulating component is 0.001 to 30 parts by weight relative to the total weight of the emulsion.
8. A method for producing microcapsules according to claim 1, wherein the active ingredient comprises at least one selected from the group consisting of fragrances, sunscreens, dyes, catalysts, antioxidants, and drugs.
9. A method for producing microcapsules according to claim 1, wherein the content of the encapsulated component is 0.5 to 3 times that of the active ingredient.
10. The method for producing microcapsules according to claim 1, wherein the content of the encapsulating component and the active ingredient is 35 parts by weight or less relative to the total weight of the emulsion.
11. Manufactured by the method for manufacturing microcapsules according to any one of claims 1 to 10, Microcapsules with a particle size of 0.1 to 8.9 μm.
12. A laundry product comprising the microcapsules described in claim 11.
13. Manufactured by a method for manufacturing microcapsules according to any one of claims 1 to 10 for manufacturing laundry products, Microcapsules with a particle size of 0.1 to 8.9 μm are used.
Citation Information
Patent Citations
Method for the preparation of oxide microcapsules filled with functional molecules and products obtained thereby
JP2003525100A
Microcapsules from emulsion polymerization of tetraalkoxysilanes
JP2009542667A
Formation of nanometer core-shell particles having a metal oxide shell
JP2010512244A
Method for manufacturing silicate shell microcapsules
JP2012505752A
Method for producing silica microcapsule
WO2022145018A1
